FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Corporate Results

Back
Morepen Laboratories consolidated net profit declines 28.15% in the March 2025 quarter
(12-May-2025, 18:10 Hours IST)  
Net profit of Morepen Laboratories declined 28.15% to Rs 20.32 crore in the quarter ended March 2025 as against Rs 28.28 crore during the previous quarter ended March 2024. Sales rose 10.11% to Rs 465.85 crore in the quarter ended March 2025 as against Rs 423.07 crore during the previous quarter ended March 2024.

For the full year,net profit rose 22.73% to Rs 118.02 crore in the year ended March 2025 as against Rs 96.16 crore during the previous year ended March 2024. Sales rose 7.17% to Rs 1811.58 crore in the year ended March 2025 as against Rs 1690.43 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales465.85423.07 10 1811.581690.43 7
OPM %9.0711.44 -9.619.38 -
PBDT42.1851.83 -19 184.09168.89 9
PBT25.7142.20 -39 155.11135.42 15
NP20.3228.28 -28 118.0296.16 23

Powered by Capital Market - Live News

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)